The Huffington Post featured TrialReach on a list of London's fastest-growing and disruptive health tech start-ups:
"TrialReach is addressing a fundamental problem in research: connecting the right people with the right researchers. A surprising 84% of cancer patients aren’t aware that a clinical trial is a possible option. Patients miss out on the opportunity to access potentially innovative treatments, especially seeing as it takes an average of 12 years for a drug to pass through trials and enter the market."
Read more at The Huffington Post.
